ITGA5 and cervical cancer: According to the expression heatmaps of integrins in GSE168009 dataset, which includes four cervical cancer patients with no durable benefit from concurrent chemoradiotherapy and five patients with durable clinical benefit, ITGA5 expression was significantly higher in the no benefit group (Figure 1D).